 During the last years there has been great progress in disease genomics. Today we know that every human disease is influenced by variations in our genes, so we have the opportunity to exploit this wealth of information for precision medicine applications. But there are several barriers that have to be overcome to achieve this goal. Finding and putting together all this information is a very cumbersome and expensive process. With our platform DysGenet Plus we want to facilitate the access to disease genomics data for every user. In DysGenet Plus we integrate information on genes and genomics variants associated with human diseases in a single resource, bringing together the power of AI and genetics to support applications in drug R&D and precision medicine.